Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Infectious Diseases

  • 1
    News

    FDA approves Xofluza for treatment of influenza

    October 24, 2018

    The FDA has approved Xofluza for acute uncomplicated influenza in people aged 12 years or older who have been symptomatic for 48 hours or less.

  • 1
    Opinion

    How much more proof do you need?

    October 16, 2018

    Why are there still proponents for lengthy IV therapy when oral therapy works just as well?

  • 1
    News

    Stepdown to oral ciprofloxacin looks safe in gram-negative bloodstream infections

    October 15, 2018

    SAN FRANCISCO – A comparison of patients with gram-negative bloodstream infections showed low 90-day treatment failure in those who switched from IV to oral ciprofloxacin within 5 days.

  • 1
    News

    In C. difficile, metronidazole may not benefit ICU patients on vancomycin

    October 14, 2018

    SAN FRANCISCO – Try fecal transplant instead.

  • 1
    News

    Need blood STAT? Call for a drone

    October 14, 2018

    BOSTON – Autonomous unmanned aerial vehicles bring blood to remote hospitals in Africa, but a U.S.-based system will need to overcome significant regulatory hurdles.

  • 1
    News

    ICU infections: Chlorhexidine wipes tame MRSA, CRE

    October 11, 2018

    SAN FRANCISCO – Decolonization tops precautions.

  • 1
    Video

    Vancomycin loading boost yields better C. diff outcomes 

    October 9, 2018

    A heightened loading dose of vancomycin may lead to faster recovery and greater efficacy in Clostridium difficile infections.

  • 1
    News

    Discharge trends for septic shock survivors remain steady

    October 8, 2018

    SAN ANTONIO – Septic shock mortality has decreased, but discharge trends for survivors have remained steady.

  • 1
    News

    FDA approves omadacycline for pneumonia and skin infections

    October 4, 2018

    The tetracycline antibiotic was approved for CABP and acute bacterial skin and skin structure infections in adults.

  • 1
    News

    Admission eosinopenia predicted severe CDI outcomes

    September 29, 2018

    Significant predictors of mortality included having more comorbidities and lower systolic blood pressure at admission.

Previous1 … 75 76 77 78 79 … 104Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences